Showing results (591-600 of 746) with videos related to

Sort By:
Pageof 75
Journal of Clinical Medicine|August 12, 2022
Bing-Neel Syndrome, a Rare Presentation of Waldenström Macroglobulinemia-A Multicenter Report by the Polish Lymphoma Research GroupJoanna Drozd-Sokołowska, Anna Waszczuk-Gajda, Magdalena Witkowska, et al.
Blood Advances|September 3, 2020
Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphomaArne Kolstad, Tim Illidge, Nils Bolstad, et al.
Current Research in Physiology|June 9, 2022
Empagliflozin restores cardiac metabolic flexibility in diet-induced obese C57BL6/J miceBingxian Xie, Wesley Ramirez, Amanda M Mills, et al.
Leukemia & Lymphoma|April 10, 2019
Consolidation with <sup>90</sup>Y ibritumomab tiuxetan radioimmunotherapy in mantle cell lymphoma patients ineligible for high dose therapy: results of the phase II multicentre Polish Lymphoma Research Group trial, after 8-year long follow-upWojciech Jurczak, Alicja M Gruszka, Anna Sowa Staszczak, et al.
Nucleic Acids Research|November 17, 2014
The H19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cellsYuan Gao, Fuju Wu, Jichun Zhou, et al.
Leukemia & Lymphoma|August 20, 2021
Tafasitamab combined with idelalisib or venetoclax in patients with CLL previously treated with a BTK inhibitorPhilipp Bernhard Staber, Wojciech Jurczak, Richard Greil, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 25, 2016
Hypophosphatemia promotes lower rates of muscle ATP synthesisDominik H Pesta, Dimitrios N Tsirigotis, Douglas E Befroy, et al.
BMJ Global Health|September 15, 2020
Does adherence to evidence-based practices during childbirth prevent perinatal mortality? A post-hoc analysis of 3,274 births in Uttar Pradesh, IndiaKatherine Ea Semrau, Kate A Miller, Stuart Lipsitz, et al.
Molecular Cell|November 13, 2012
The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesisJohn E Dominy, Yoonjin Lee, Mark P Jedrychowski, et al.
Blood Advances|September 9, 2025
Outcomes after transition from ibrutinib to zanubrutinib in patients with Waldenström macroglobulinemia from the ASPEN studyRamón García-Sanz, Roger G Owen, Wojciech Jurczak, et al.
Pageof 75